Condensed Balance Sheets - USD ($)	Jan. 31, 2023	Jul. 31, 2022
CURRENT ASSETS
Cash and cash equivalents	$ 19,218	$ 19,312
Prepayment	3,287	2,594
TOTAL CURRENT ASSETS	22,505	21,906
NON-CURRENT ASSETS
Plant and equipment, net	1,227	1,599
TOTAL NON-CURRENT ASSETS	1,227	1,599
TOTAL ASSETS	23,732	23,505
CURRENT LIABILITIES
Accrued liabilities	2,500	2,500
Amount due to a director	9,776	7,326
TOTAL CURRENT LIABILITIES	12,276	9,826
TOTAL LIABILITIES	12,276	9,826
STOCKHOLDERS’ EQUITY
Common stock – Par value $ 0.001; Authorized: 75,000,000 shares; Issued and outstanding: 5,040,000 and 5,040,000 shares as of January 31, 2023 and July 31, 2022, respectively	5,040	5,040
Additional paid in capital	34,560	34,560
Accumulated deficit	(28,144)	(25,921)
TOTAL STOCKHOLDERS’ EQUITY	11,456	13,679
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 23,732	$ 23,505

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.